Tenaya Therapeutics, Inc. (TNYA)
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.
$0.74-0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+10.3%
The outlook
Tenaya Therapeutics, Inc. currently reads as neutral based on strong buy — 1.3 avg of 6 analysts, below its 50- & 200-day averages, 11% of the way from its 52-week low to high, avg target +440% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 6 analysts
Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Price targetAvg target +440% vs current price
Analyst price target
~12-month · 6 analysts$4.00average target+440.2% vs now
Now $0.74
Low $2.00High $8.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$160.7M
52-wk high
$2.35
52-wk low
$0.53
50-day avg
$0.78
200-day avg
$0.91
Trailing P/E
—